Posts
The Crossover #1: MoneyLion vs. Acorns
Want to get these in your inbox to never miss an edition? Subscribe to The Crossover today! MoneyLion: A curious situation “The elevator to success is out of order. You are going to have to take the stairs… one step at a time.” – Joe Girard On January 19th, 2022, Acorns Inc. announced that they will forgo their…
Read MoreApple’s Worldwide Developers Conference
Apple’s Worldwide Developers Conference WWDC had the internet abuzz yesterday with Apple’s new features. Here’s a recap: Text message editing and ‘undo send’ – but only for 15 min post send Apple Pay Later, a new Buy Now Pay Later service from Apple Share Play: Simultaneous streaming of music and video across devices. Will be…
Read MoreRescheduling cannabis, the budtender’s influence, and the illicit market.
The Drug Enforcement Agency (DEA) currently has five categories of substances, with cannabis currently listed as a Schedule I. The drugs on the scheduled substances list are in order from most dangerous and addictive to least dangerous and addictive. This means cannabis is currently listed as among the most dangerous and addictive drugs as a schedule I substance – with “no currently accepted…
Read MoreSteward goes All-in on Value-Based Care with CareMax
This week’s healthcare round-up includes analysis on the Steward Health Care and CareMax value-based deal
Read MoreNew York State Is Crippling Its Crypto Economy
New York State passed another piece of anti-crypto regulation. With consumers and businesses getting affected across the board, New York State is becoming one of the most unfriendly crypto states in the US. New York City has been the epicenter of finance for a few centuries now, dating back to 1817 when the state established…
Read More“The Golden Age of Older Rectums”
BUSINESS “The Golden Age of Older Rectums” Private equity-backed firms are buying out gastroenterology practices left and right. There are no signs of slowing down. As one investment manager said: We are in the Golden Age of older rectums. The DeetsAround 10% of all 14,000 gastroenterologists in the U.S. are currently partners or employed by a private equity-backed firm. The three largest…
Read More